CClinicalTrials.gg
Status unknownNCT05051371Updated Sep 21, 2021

Postoperative Residual Curarization in Elderly Patients in Post-anesthesia Care Unit

An observational study in Postoperative Residual Curarization and Geriatrics, sponsored by Ankara City Hospital Bilkent. Status unknown at 1 site in Turkey. Open to participants aged 65 Years to 95 Years. Per ClinicalTrials.gov, last updated 2021-09-21.

Sponsored by Ankara City Hospital Bilkent · Observational

The sponsor has not verified this record recently (last verified Sep 2021), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
65 Years to 95 Years
Sex
All
01

Study summary

In this study, we aimed to determine the knowledge levels and approaches of anesthesiologists working in our clinic about postoperative residual curarization(PORC) in elderly patients with a questionnaire. In addition, we aimed to determine the incidence of PORC and factors associated with PORC in the recovery unit in elderly patients over 65 years of age who underwent surgery under general anesthesia using muscle relaxants with a prospective observational study.

Read the detailed description

Postoperative residual curarization (PORC) after general anesthesia is an important complication that can cause adverse patient outcomes, including symptoms of airway obstruction, hypoxia, respiratory distress, muscle weakness, and dyspnea in the early and late stages.

Anticholinesterase agents are commonly used to reverse neuromuscular blockade. Even with the use of anticholinesterase, severe PORC can be seen. The use of anticholinesterases in elderly patients is controversial due to the high side-effect profile.

Sugammadex, which has been widely used with its approval by the United States Food and Drug Administration in 2015, is a reverse agent that acts through a different mechanism than traditional anticholinesterase agents (it is a cyclodextrin molecule that encapsulates steroid neuromuscular blockers). Compared to neostigmine, sugammadex reverses neuromuscular blockade faster and more reliably.

In this study, we aimed to determine the knowledge levels and approaches of anesthesiologists working in our clinic about postoperative residual curarization(PORC) in elderly patients with a questionnaire. In addition, we aimed to determine the incidence of PORC and factors associated with PORC in the recovery unit in elderly patients over 65 years of age who underwent surgery under general anesthesia using muscle relaxants with a prospective observational study.

The first phase of the study is a prospective observational study. Elderly patients (>65) who are scheduled to undergo elective surgery under general anesthesia and require intubation using muscle relaxants will be screened for PORC using Train of four monitor in the recovery unit.

In the second phase of the study, an online questionnaire with 15 questions will determine the knowledge and attitudes of anesthesiologists working in our clinic on the use of muscle relaxants and reversing agents in elderly patients, the use of neuromuscular monitoring and PORC.

02

Conditions studied

  • Postoperative Residual Curarization
  • Geriatrics

Keywords

  • Postoperative residual curarization
  • Geriatrics
  • Train of four
03

In context

Delayed Emergence from Anesthesia

99 studies on the registry are indexed under Delayed Emergence from Anesthesia; 15 are open to participants now.

This study's planned enrollment of 100 is below the median of 120 across 39 observational studies indexed under Delayed Emergence from Anesthesia.

Browse Delayed Emergence from Anesthesia studies →

Lead sponsor

Ankara City Hospital Bilkent is the lead sponsor of 424 studies on the registry; 105 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years to 95 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Electively operated elderly patients >65 years old under general anesthesia

Inclusion criteria

  • age >65
  • general anesthesia using non-depolarizing neuromuscular blocker

Exclusion criteria

Exclusion Criteria:

  • Patients with an ASA score greater than 3
  • Those with contraindications to anesthetic drugs
  • Those with neuromuscular, neurological and psychiatric diseases
  • Patients in whom TOF monitoring is not possible in the ulnar nerve region
  • Patients with advanced renal failure
  • Patients with advanced hepatic insufficiency
  • Those with decompensated heart failure
  • Patients with BMI\<18 and BMI>30
  • Patients with uncontrolled hypertension, uncontrolled diabetes, pheochromocytoma, thyroid dysfunction
  • Those who are incapable of reading and signing the consent form
  • Patients who do not want to sign the consent form
  • Patients deemed unsuitable by the investigator
  • Those with chronic opioid use
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No

Interventions

  • DeviceTrain of four monitoring

    Train of four monitoring in postoperative care unit

06

What researchers measure

Primary outcomes

  1. The incidence of postoperative residual curarization

    The incidence of elderly patients that Train of Four(TOF) rate \<0.9 in the postoperative care unit

    Time frame: through study completion( anticipated 5 months)

07

Study locations

1 of 1 sites recruiting
  • Ankara City Hospital
    Ankara, 06800, Turkey
    • Aysun Postaci, As.Prof.Dr. · Contact
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 21, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05051371
Lead sponsor
Ankara City Hospital Bilkent
Responsible party
aysun postaci (Ass. Prof. Dr. Nadide Aysun Postaci, Ankara City Hospital Bilkent) — Principal investigator
First posted
Sep 21, 2021
Start date
Aug 15, 2021
Primary completion
Dec 2021 (estimated)
Completion
Dec 2021 (estimated)
Last update
Sep 21, 2021

Study contacts

Aysun Postaci
Contact
aysunposta@yahoo.com
+90 5323520383
Aysun Postaci
principal investigator · Ankara City Hospital Bilkent

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion